Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC57H73FN10O11S2 |
InChIKeyRTFQFPZKDYMMMJ-RIAKQDHQSA-N |
CAS Registry2381320-35-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 28 Aug 2019 |